[No place for ondansetron in young children with gastroenteritis and persistent vomiting]

Area of Science:

• Pediatric Gastroenterology
• Clinical Pharmacology
• Emergency Medicine

Background:

• Gastroenteritis with persistent vomiting is common in young children.
• Ondansetron is an antiemetic medication used to manage vomiting.
• Standard care often involves oral rehydration solution (ORS).

Purpose of the Study:

• To compare the efficacy of a single dose of ondansetron versus standard care (ORS) in young children with gastroenteritis and persistent vomiting.
• To assess the impact of ondansetron on ORS use and hospital referrals.
• To investigate potential adverse effects, specifically diarrhea.

Main Methods:

• A comparative study was conducted in out-of-hours primary care services.
• Young children presenting with gastroenteritis and persistent vomiting were enrolled.
• One group received a single dose of ondansetron; the control group received standard care (ORS).

Main Results:

• Vomiting decreased more frequently in the ondansetron group within the initial hours.
• Ondansetron did not significantly affect the use of ORS or reduce hospital referrals.
• Four of five other studies reported diarrhea 2-3 times more often with ondansetron compared to placebo in children with gastroenteritis.

Conclusions:

• The limited clinical benefit of ondansetron in reducing vomiting in pediatric gastroenteritis may not outweigh the potential risk of increased diarrhea.
• Further investigation into the safety profile of ondansetron, particularly regarding diarrhea, is warranted in this population.
• The use of ondansetron for vomiting associated with gastroenteritis in children requires careful consideration of its risk-benefit ratio.